Norway· NO-ID_5B4E278D-A0AF-4BFB-BFFE-48C4CE859399
Lorviqua
A lorlatinib product containing lorlatinib, registered in Norway by Abacus Medicine A/S. The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Lorlatinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01ED05 (lorlatinib), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Lorlatinib · ATC L01ED05
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lorlatinib costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lorlatinib · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$192.44
The record
At a glance
FEST (Norway)- Active substance
- Lorlatinib
- Manufacturer
- Abacus Medicine A/S
- Country
- Norway (NO)
- ATC code
- L01ED05
- ATC class
- Lorlatinib
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_varenummer41177490NOK 70161.3
- no_merkevare_idID_5B4E278D-A0AF-4BFB-BFFE-48C4CE859399
- gtin5712440015555
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
570 interactions on record for lorlatinib.
Graded by severity as the source publishes them — 119 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lorlatinib · interactions on record
570 records
- 119 severe
- 439 moderate
- 12 minor
Most severe, free to view
- LonafarnibA16AX20severe
- BerotralstatB06AC06severe
- VoxelotorB06AX03severe
- RanolazineC01EB18severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lorlatinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesLorbrenaU.S. Pharmaceuticals
- FinlandLorviquaPfizer Europe MA EEIG
- CzechiaLORVIQUAPfizer Europe MA EEIG, Bruxelles
- SpainLORVIQUA 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULAPfizer Europe Ma Eeig
- FranceLORVIQUA 25 mg, comprimé pelliculéPFIZER EUROPE MA EEIG (BELGIQUE)
- BelgiumLorviqua 25 mgPfizer Europe MA
- IcelandLorviquaPfizer Europe MA EEIG*
- NetherlandsLorviqua, 25 mg filmomhulde tablettenPfizer Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Lorviqua
- Liechtenstein · Lorviqua
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/812a4a8d-97fb-43ce-a140-177469c4215b GET /v1/drugs/812a4a8d-97fb-43ce-a140-177469c4215b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett, filmdrasjert",
"source": "fest",
"status": "A",
"atc_name": "Lorlatinib",
"merkevare_id": "ID_5B4E278D-A0AF-4BFB-BFFE-48C4CE859399",
"name_form_strength": "Lorviqua tab 25 mg",
"prescription_group": "C"
}See everything about lorlatinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.